In our CML-induced rat model, administration of LL-KF140 inhibited the accumulation of CML in the blood and liver and the expression of the RAGE in the liver but had no effect on serum AST, ALT, and lipid levels. The gene discussed is GPT; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.